Hidetomo Nakamoto - Concepedia

Author

Hidetomo Nakamoto

Also Known As

H NAKAMOTO, H Nakamoto, H. Nakamoto, H., Nakamoto, HIDETOMO NAKAMOTO, Hidetomo NAKAMOTO, Hidetomo Nakamoto, Hirose Nakamoto, Masashi Tomo, Munekazu Ryuzaki

460

Publications

6.5K

Citations

H-Index

138

Concepts

All Affiliations

Saitama Medical University Japanese Society for Dialysis Therapy Keio University Tokyo Women's Medical University The University of Tokyo

About

Hidetomo Nakamoto is an author at Saitama Medical University specializing in medicine, nephrology, and chronic kidney disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	53	2.5K
2	Public Health	6	6	548
3	Health Sciences	2	2	57
4	Engineering	1	1	18
5	Anesthesia	1	1	10

Hidetomo Nakamoto

128

Publications

5.8K

Citations

H-Index

Page 1

	Year	Citations
Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: a Phase III, randomized, double-blind, placebo-controlled study Hitoshi Kumagai, Toshiya Ebata, Kenji Takamori, Nephrology Dialysis Transplantation	2009	348
Overview of Regular Dialysis Treatment in Japan (as of 31 December 2008) Shigeru Nakai, Kazuyuki Suzuki, Ikuto Masakane, Therapeutic Apheresis and Dialysis DialysisRenal PathologyDecember 2008Dialysis TherapyDialysis Facilities	2010	228
Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD Hiromichi Suzuki, Yoshihiko Kanno, Soichi Sugahara, American Journal of Kidney Diseases HypertensionUrologyRenal FunctionMedicineRenal Inflammation	2004	210
Overview of Regular Dialysis Treatment in <scp>J</scp>apan (as of 31 <scp>D</scp>ecember 2011) Shigeru Nakai, Yuzo Watanabe, Ikuto Masakane, Therapeutic Apheresis and Dialysis DialysisDialysis TherapyDialysis FacilitiesLogistic AnalysisRenal Function	2013	196
Encapsulating Peritoneal Sclerosis—A Clinician's Approach to Diagnosis and Medical Treatment Hidetomo Nakamoto Peritoneal Dialysis International Peritoneal SclerosisMedical TreatmentOpaque TissueSystemic SclerodermaContinuous Peritoneal Dialysis	2005	174
Annual dialysis data report for 2018, JSDT Renal Data Registry: survey methods, facility data, incidence, prevalence, and mortality Kosaku Nitta, Shunsuke Goto, Ikuto Masakane, Renal Replacement Therapy Glomerular DiseaseJapanese SocietyDialysisRenal PathologyDialysis Therapy	2020	163
Recommendations on the Management of Encapsulating Peritoneal Sclerosis in Japan, 2005: Diagnosis, Predictive Markers, Treatment, and Preventive Measures Yoshindo Kawaguchi, Akira Saitō, Hideki Kawanishi, Peritoneal Dialysis International Translational MedicineHemodialysisUrologyPredictive MarkersPeritoneal Dialysis	2005	159
Annual dialysis data report 2017, JSDT Renal Data Registry Kosaku Nitta, Ikuto Masakane, Norio Hanafusa, Renal Replacement Therapy	2019	155
Efficacy and Safety of a Novel ĸ-Agonist for Managing Intractable Pruritus in Dialysis Patients Hiroo Kumagai, Toshiya Ebata, Kenji Takamori, American Journal of Nephrology	2012	152
Effects of oral AVP receptor antagonists OPC-21268 and OPC-31260 on congestive heart failure in conscious dogs Motoko Naitoh, Hiromichi Suzuki, M Murakami, American Journal of Physiology-Heart and Circulatory Physiology HypertensionHeart FailureCardiovascular PharmacologyPharmacotherapyExperimental Pharmacology	1994	137

Page 1